Suggestions
Keith Wycoff
Vice President of Research at Planet Biotechnology, Inc.
Professional Background
Keith Wycoff is a distinguished leader in research and development specializing in the field of human therapeutics. With extensive expertise in the creation of antibodies, receptor-Fc fusions, and various other recombinant proteins, his work is grounded in the innovative application of plant-based expression platforms. Keith has successfully established himself as a leading figure in his industry, demonstrating a unique ability to marry scientific rigor with entrepreneurial spirit.
As Vice President of Research at Planet Biotechnology, Inc., Keith oversees significant advancements in biotherapeutics, where his leadership and strategic vision contribute to the development of groundbreaking therapies that aim to address some of the most pressing health challenges today. Keith's roles have also extended beyond corporate boundaries as he has actively engaged in fostering collaborations among academic institutions and the biotech industry—facilitating synergy among experts across multiple disciplines for the greater advancement of biological research.
With a proven track record of securing over $25 million in non-dilutive funding through government grants and contracts, Keith is recognized as a highly effective rainmaker. His capability to navigate the funding landscape has been pivotal not only to his company but also to drive innovation in the industry. His contributions extend beyond financial growth, promoting a culture of research excellence and collaborative progress.
Education and Achievements
Keith's academic journey began at the University of California, Davis, where he earned both his Bachelor's and Master's degrees in Botany. It was here that he developed a strong foundation in plant sciences, which would later serve as a critical element of his professional identity. To further his academic pursuits, he obtained his PhD in Cellular and Developmental Biology from Harvard University Graduate School of Arts and Sciences. This esteemed institution honed his research skills and enriched his scientific knowledge, paving the way for his revolutionary work in therapeutics.
Throughout his career, Keith has held various positions that reflect his commitment to advancing biotherapeutics. His tenure as Board Member and Biotherapeutics/Genomics Committee Chair at Life Science Angels highlights his leadership in the investment community, guiding strategic decisions that propel forward-thinking biotech initiatives. Additionally, during his past roles at organizations like Seal Rock Therapeutics and his postdoctoral fellowships at prestigious institutions including UCLA, the Noble Foundation, and the Salk Institute for Biological Studies, Keith has cultivated a robust network of professional relationships and collaborations that enrich his work.
In every capacity, Keith has demonstrated an unwavering dedication to scientific discovery and innovation, resulting in impactful contributions to the realms of biotechnology and therapeutics.
Achievements
Keith Wycoff is highly regarded for his numerous achievements in the biotechnology industry. His role at Planet Biotechnology, Inc. not only involves pioneering research but also extends to mentoring aspiring scientists and fostering an inclusive environment for innovation. The strategic partnerships he has initiated align with his vision of connecting academia with industry to create sustainable biotherapeutic solutions.
Under his leadership, numerous projects have successfully transitioned from concept through funding and ultimately to implementation, underscoring Keith's knack for turning scientific ideas into viable products that can enhance patient care.
His academic prowess, coupled with a strong entrepreneur spirit, make him a standout figure in the domain of biotherapeutics. With every milestone achieved and every barrier broken, Keith continues to influence the field, reinforcing the relevance of plant-based systems in creating advanced therapeutic solutions.
